FData and analytics firm PitchBook published its full year 2023 report on the insurtech industry in early March, showing that activity from the venture capital funds in the space delivered a six-year low in both the number of deals completed (486) and the aggregate value of deals ($5.6bn). Â
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.Â
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp
Decision by the US Court of Appeals for the Eighth Circuit affirmed the summary judgment…
Q&A: Mitchell Schepps, Senior Managing Director, Aon
Schepps offers his views on the current state of the longevity architecture in the US.
New Stress Test Shows UK Bulk Purchase Annuity Insurers on Solid Ground
Recent S&P Global stress test shows UK life insurers with a coverage ratio of 200%…
New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market
Life settlement market continuing growth trajectory despite overall reduction in life settlement provider licenses.
